Expired contract
NHS National Framework Agreement for the Supply of Adalimumab
Details
- Buyer
- NHS England
- Supplier(s)
- Value
- GBP 164,000,000
- Duration
- 1 year
- Topic
- Pharmaceutical products
- Published
- 7 May 2019
- Source
- ContractsFinder
Tender description
NHS National Framework Agreement for Adalimumab Injection, Framework Period: 1 December 2018 - 30 November 2019 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months Tender Reference: CM/PHR/18/5567
Timeline
- Completed: Award date1 December 2018
- Completed: Award published7 May 2019Current notice
- Completed: Contract expiry date30 November 2019
About the buyer
NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
6 similar open tenders
See more open tenders related to NHS National Framework Agreement for the Supply of Adalimumab.
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to NHS England.
BuyersCountValue
- 455£2.1bn
- 367£249.3m
- 357£15.0bn
- 293£2.8bn
- 263£19.7bn
- 253£892.5m
- 246£509.3m
- 203£1.0bn
- 140£895.5m
- 115£59.6m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
